17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level (Q46755244)

24 December 2017

title

17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level (English)

1 reference

24 December 2017

author name string

Kai Kappert

1

1 reference

24 December 2017

Evren Caglayan

2

1 reference

24 December 2017

Michael Huntgeburth

3

1 reference

24 December 2017

Anselm T Bäumer

4

1 reference

24 December 2017

Jan Sparwel

5

1 reference

24 December 2017

Manuela Uebel

6

1 reference

24 December 2017

Stephan Rosenkranz

7

1 reference

24 December 2017

publication date

14 October 2005

1 reference

24 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

24 December 2017

volume

290

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

H538-46

1 reference

24 December 2017

Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Bacterial toxins that target Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Sex hormones and coronary disease: a review of the clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Down-regulation of Rac-1 GTPase by Estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Multiple growth factors are associated with lesions of atherosclerosis: specificity or redundancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Atherosclerosis is an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Coordinate Notch3-hairy-related transcription factor pathway regulation in response to arterial injury. Mediator role of platelet-derived growth factor and ERK

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00240.2005

10.1152/AJPHEART.00240.2005

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16227346

1 reference

24 December 2017